Displaying 101 - 110 of 518

Strategic Plan 2022-2025

We at AACE are continuing to lead the way in clinical endocrinology through our brand-new strategic plan that we are sharing here with our community. A strategic plan really helps us prioritize goals and objectives so our organization can move closer to achieving our mission and vision. Here is an overview of 3 of the goals on our plan:
  • The first goal is on the topic of endocrine care teams, that we will work further on developing endocrinologists as leaders and work harder at offering a more inclusive learning environment for all of those on the endocrine care team.…
more

10 Things PCPs Need to Know About Common Endocrine Disorders

As endocrine and metabolic disorders are on the rise, it is vital for primary care providers (PCP) to have a role in patient management. Many endocrine patients have lifelong conditions that require long-term surveillance and co-management with endocrinologists. To help PCP care teams stay up to date with the latest advancements in clinical practice guidelines, interventions, and patient care, we’ve asked our leading endocrine experts to share clinical pearls of knowledge when it comes to common endocrine disorders screening, diagnosis, and treatment options. 10 things primary care teams… more

Learn the Criteria to Volunteer on a Committee

All AACE members in good standing are invited to select up to 3 committees for which they would like to be considered, and requests will only be accepted during the annual application and review period. Members may volunteer to serve on up to 3 disease state networks at any time. What are the criteria for committee member appointments? AACE members are appointed to committees based on background and interest in a particular field or area of practice and the skills needed to contribute to the committee’s charge(s). Candidate submissions are reviewed by AACE’s President-Elect with… more

Management of Hypertriglyceridemia in Patients with Diabetes Mellitus

Written by: Vishnu Priya Pulipati, MD, Warren Clinic Endocrinology, Tulsa, Oklahoma Diabetes mellitus (DM) is a globally prevalent chronic disease that directly caused 1.5 million deaths worldwide in 2019. Diabetes and associated dyslipidemia are major contributors to cardiovascular disease (CVD), the leading cause of morbidity and mortality in patients with DM. Diabetic dyslipidemia is characterized by elevated fasting and postprandial serum triglycerides (TG), low high-density lipoprotein cholesterol (HDL-C), elevated low-density lipoprotein cholesterol (LDL-C), and… more

Medicare Payment Rules

By: Julius W. Hobson, Jr. On November 2, 2021, the U. S. Department of Health and Human Services (HHS) Centers for Medicare and Medicaid Services (CMS) released several final Calendar Year (CY) 2022 payment rules. These rules covered the following areas:
  • Physician Fee Schedule Fee for Service (PFS)
  • Hospital Outpatient and Ambulatory Surgical Centers
  • Home Health
  • End Stage Renal Disease
2022 Physician Fee Schedule The CY 2022 PPS conversion factor will be $33.59, a decrease of $1.30 from the CY 2021… more

Integrating CGM Into Clinical Practice

Step By Step CGM Guide Here’s a step-by-step guide to getting started with CGM devices in your practice. What are the indications for CGM in persons with diabetes mellitus? GUIDELINE: According to the American Diabetes Association’s "Standards of Care in Diabetes—2024," the following individuals would benefit from routine use of continuous glucose monitoring (CGM):
  • Real-time CGM (rtCGM) [Recommendation 7.14, grade A] or intermittently…
more

Guidelines for Nomination of AACE Officers

The AACE Nominating Committee encourages you to consider submitting the name of an AACE member who you feel may be a good candidate for the Officer positions of President Elect, Treasurer and Secretary (Attributes and Background of an Officer & Bylaws Eligibility for Officers).Please confirm that they are willing to make the commitment to serve (Duties and Responsibilities for Officers) and submit… more

CGM Device Comparison

CGM Device Comparison Compare and contrast FDA-approved CGM systems to find what is right for each individual patient and your practice.   Personal CGM Devices Device Name Frequency of Glucose Readings Data Type Approved Ages Location for Placement Sensor Life Calibration Warm-up Time Potential Interfering Substances Alerts/Alarms Linksmore

Action Plan

Action Plan Action plans are an important part of diabetes care and can be incorporated with the use of CGM.
  • Consider making this action plan a template that can be adapted to a format that works for your practice. Consider utilizing drop down options, fill-in spaces, etc. to easily update, save, share, and print. For example:
    • Column 1 Color Code: All spaces should have a drop down to color Red, Yellow, or Green
    • Column 2 Metric: Drop down options for all metrics that you consider applicable (GMI, average…
more

Glossary

Glossary Definitions to common terms you might encounter when using CGM. Term Definition Ambulatory glucose profile (AGP) Continuous glucose monitoring data are shown visually in the ambulatory glucose profile. A summary of glucose values from the report period (ideally 14 days), with median (50%) and other percentiles are shown as if occurring in a single 24-hour day (midnight to midnight). AGP Report Ambulatory glucose profile report: a standardized 1-page continuous glucose monitoring report that provides glycemic activity in both graphical and quantitative… more